ASCO living guideline update (2026.3.1) on therapy for stage IV non-small cell lung cancer with driver alterations, maintained by a standing expert panel that continuously and systematically reviews new evidence; the abstract gives no specific recommendations.
Guideline
Reuss et al. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1